ASX CODE: BNO

Bionomics ASX BNO PTSD drug post traumatic stress disorder Phase 2 findings BNC210

Further analysis provides greater insight into phase 2 findings of Bionomics’ PTSD drug

Biopharmaceutical company Bionomics (ASX: BNO) has reported positive results from further data analysis of a phase two trial involving the BNC210 drug to treat...
Bionomics ASX BNO US drugmaker Bristol-Myers Squibb experimental cancer trial

Bionomics and US drugmaker Bristol-Myers Squibb kick off experimental cancer trial

Biopharmaceutical company Bionomics (ASX: BNO) has begun the first experimental trial of its proposed cancer drug, BNC105, which will roll out at 15 sites...

RECENT POSTS

STOCK SUMMARY

HOT TOPICS

TRENDING POSTS